about
Vitamin D and urological cancersPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsVitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytesSeasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude.Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation.Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer modelATP-Binding Cassette Transporter Structure Changes Detected by Intramolecular Fluorescence Energy Transfer for High-Throughput Screening.Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment.CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.Antiangiogenic cancer treatment: The great discovery and greater complexity (Review).Vitamin D in oncology.Molecular aspects of vitamin D anticancer activity.Differentiation therapy of acute myeloid leukemia.Vitamin D in cancer chemoprevention.Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia.20-hydroxyvitamin D₃ inhibits proliferation of cancer cells with high efficacy while being non-toxic.The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells.Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer.Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.Exploring vitamin D metabolism and function in cancer.Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma.
P2860
Q26739735-CFBB7F13-9D37-4ED9-B793-D10259D49A42Q26991440-4DDC2BF1-2832-49A7-8CEE-D3EB58A7EE91Q28393501-FD185E95-F857-44CB-94E2-DE351767202EQ33686275-02941F99-BE99-43F2-B6CB-38C335CF239CQ33839179-F46238AF-7D91-485C-A916-6E940D3302ABQ34777428-E4AABDDA-3270-4037-9479-AD83C8362414Q35617947-97CA8A5D-7EDB-4126-8CEA-AC656FD26ED4Q35987385-D0D02AD0-C6F7-4C59-BF31-14D323D9D5B6Q36819584-5D70D664-26D2-467F-8769-BB94A53F8DCDQ37337814-061AD81D-8443-4DB8-8766-109AED11F9C1Q37936093-41214ED9-99E2-4451-B2B3-5910DCD06405Q38042081-7B83C1DB-111F-4979-90A3-935966A0C86EQ38161360-C4CD1BFB-E822-449F-B6F5-5ECD4A06B331Q38412880-9D39B7F2-52ED-4D21-AEBB-86953948A875Q38804186-3D6874A6-221E-49D7-96CA-ED59132DF7A3Q39037456-9F0C4C29-FA44-4125-B92A-4163F986E03DQ39383582-E521C3A8-9DF7-45CE-A105-E83E12588EF3Q39796064-09B98C74-2292-4730-9C12-9C4B3F7B8832Q41098254-C858F17B-2A3D-4C17-9473-C195401F4992Q41999286-91740DFC-5780-4690-8D0D-21C1077A6B3BQ42598206-80AEE8E0-3271-4D33-B05E-66E70224DE6DQ52587327-7BDD2A1D-AAEE-4214-B9C9-87197F64B2BDQ53154285-B8BA5499-376F-4343-B3E7-A8E1CA09DD1D
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Vitamin D in combination cancer treatment.
@en
Vitamin D in combination cancer treatment.
@nl
type
label
Vitamin D in combination cancer treatment.
@en
Vitamin D in combination cancer treatment.
@nl
prefLabel
Vitamin D in combination cancer treatment.
@en
Vitamin D in combination cancer treatment.
@nl
P2093
P2860
P356
P1433
P1476
Vitamin D in combination cancer treatment.
@en
P2093
Candace S Johnson
Donald L Trump
P2860
P304
P356
10.7150/JCA.1.101
P577
2010-07-15T00:00:00Z